UNEVALUABLE THERAPY

UNEVALUABLE THERAPY was reported 26 times

These drug classes are most commonly taken by patients reporting UNEVALUABLE THERAPY:

# Drug Count
0 Corticosteroid [EPC] 3
1 GLP-1 Receptor Agonist [EPC] 3
2 Loop Diuretic [EPC] 3
3 Endothelin Receptor Antagonist [EPC] 2
4 Factor Xa Inhibitor [EPC] 2
5 Interleukin-12 Antagonist [EPC] 2
6 Interleukin-23 Antagonist [EPC] 2
7 Prostacyclin Receptor Agonist [EPC] 2
8 Vitamin B12 [EPC] 2
9 Vitamin C [EPC] 2
10 Vitamin D [EPC] 2
11 Acetylcholine Release Inhibitor [EPC] 1
12 Aldosterone Antagonist [EPC] 1
13 Angiotensin 2 Receptor Blocker [EPC] 1
14 Anti-anginal [EPC] 1
15 Antidote [EPC] 1
16 Antidote for Acetaminophen Overdose [EPC] 1
17 Antirheumatic Agent [EPC] 1
18 Catechol-O-Methyltransferase Inhibitor [EPC] 1
19 Dihydropyridine Calcium Channel Blocker [EPC] 1
20 Folate Analog [EPC] 1
21 HER2/neu Receptor Antagonist [EPC] 1
22 HMG-CoA Reductase Inhibitor [EPC] 1
23 Insulin Analog [EPC] 1
24 Interleukin-6 Receptor Antagonist [EPC] 1
25 Janus Kinase Inhibitor [EPC] 1
26 Kinase Inhibitor [EPC] 1
27 Mucolytic [EPC] 1
28 Neuromuscular Blocker [EPC] 1
29 Nicotinic Acid [EPC] 1
30 Non-Standardized Food Allergenic Extract [EPC] 1
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1
32 Nucleoside Metabolic Inhibitor [EPC] 1
33 Opioid Agonist [EPC] 1
34 P2Y12 Platelet Inhibitor [EPC] 1
35 Phosphodiesterase 5 Inhibitor [EPC] 1
36 Platelet Aggregation Inhibitor [EPC] 1
37 Platinum-based Drug [EPC] 1
38 RANK Ligand Inhibitor [EPC] 1
39 Sulfonylurea [EPC] 1
40 Thiazide-like Diuretic [EPC] 1
41 Tumor Necrosis Factor Blocker [EPC] 1
42 Vitamin A [EPC] 1